At AAAAI 2026, Torres highlighted phase 3 peach immunotherapy research, nanostructure preclinical models, and a phase 2 prebiotic trial for LTP allergy.
María José Torres Jaén, MD, PhD
Advertisement
María José Torres Jaén, MD, PhD, from Hospital Regional Universitario de Málaga.
Articles by María José Torres Jaén, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial
2
Sutezolid Shows Promise as Safer Oxazolidinone in Novel 4-Month TB Regimen
3
Tezepelumab Reduces Severe Asthma Exacerbations by 70% in Phase 4 PASSAGE
4
twiist AID System Improves HbA1c, Time in Range in Insulin-Treated Type 2 Diabetes
5